Alpha-Rich Ideas
Strong Fundamentals And Deep Value Make Associated Estates A Buy
by Dane Bowler
Editor's notes: Multi-family REIT AEC has sector and company-level tailwinds behind it. REIT expert Dane Bowler sees 33% upside as its multiple reflects its exceptional performance.
Silicon Motion: Significant Opportunity In Light Of Near-Term Headwinds
by Ashraf Eassa
Editor's notes: Beaten-down SIMO is poised for market share gains along with an underlying secular growth story. As uncertainty about the LTE business dissipates, shares could climb 60%.
ARPI: A Fundamentally Flawed Business Model Gives Shorts An Opportunity
by Josh Arnold
Editor's notes: American Residential Properties is dizzyingly overvalued given its flawed business model and growth limitations. Arnold sees at least 40% downside, with potentially 75% downside if valued based on earnings capabilities.
Rick's Cabaret Is A Cheap 'Sin' Stock Worth More Than Double
by Igor Novgorodtsev
Editor's notes: Adult entertainment operator RICK is sinfully cheap and could be worth double the market price. Upcoming catalysts include a REIT conversion and judgments on pending lawsuits.
Stocks Moving From Alpha-Rich Articles
Empresas ICA (ICA) is +18% since Brian McCormick's June 18th article laid out upside of nearly 100%.Read article »
Atlas Pipeline Partners (APL) is +26% from Dec. 10, 2012, when Thomas Lott highlighted a nice entry point for the stable, growing dividend payer. Read article »
Breaking Alpha-Rich Articles (for Pro Subscribers or those with free trial)
Oil Company Offers Investors Considerable Upside Despite Its Problems by Caiman Valores
Community Bank: 20% Discount To Tangible Book, Bright Long-Term Prospects by Intangible Valuation
This E&P Company Is Not Alone In Resolving Covenant Issues by Benjamin Mackovak
Strong Fundamentals And Deep Value Make Associated Estates A Buy by Dane Bowler
Long Ideas
Sensient: Solid Growth And Much Cheaper Than The Competition by Matthew Frankel
Disney Keeps Getting Better And Better by Harlan Kessler
DNO International: A Grossly Undervalued Kurdish Oil Play by Economics Fanatic
EPAM Systems: Growth Profile Is Not Fully Reflected In The Share Price by Stock Gamer
Zynga's 2 Recent Management Changes Are Key To Future Operations by The Focused Stock Trader
NQ Mobile: Upside Play On Mobile Security by Steven Weitz
Cirrus Logic: Know Your Risks, Or Risk Your Future by Timing Best Buy
Lydall Is Undervalued With Improving Fundamentals by John Leonard
JDS Uniphase: Why Bulls Should Be Excited About This Communication Equipment Maker by Fusion Research
3 Things You Didn't Know About Car Charging Group... That Make A Big Difference by Market Exclusive
Apple: Strong Start To The Second Half Could Continue by Bret Jensen
This Steel Industry Titan Is Poised To Rebound 30% by StreetAuthority
Cloud Security Is Another Enterprise Market Microsoft Is Going After by SoundView Technology Group
ImmunoCellular Therapeutics' Immune Modifying Approach To Cancer Is Worth Watching by SciFi Advisor
Nokia To Buy All Of Nokia Siemens Networks by Jacob Steinberg
Mark Pincus May Just Have Saved Zynga by Mark Meadows
Buy The BDC With A Buyback Yield Of 13% by Stone Fox Capital
Lincoln Shares Tanked, Now What? by Brian Grosso
Is Macy's Back On Top? by Thinking Big
Dawson Geophysical: Honest And Realistic Management Adds To Other Strong Reasons To Buy by Martin Vlcek
What Is On The Horizon For XOMA? by C.R. Jackson
Krispy Kreme Doughnuts: 'Krispy' Growth, 'Kremey' Returns by Philip Saglimbeni
Celgene Vs. Johnson & Johnson: The Race In Blood Cancer by Peter Geschek
Adidas: Looming World Cup And Strong Fundamentals Make It More Attractive Than Nike by Black Coral Research
Document Security Systems: Patent Litigation Against Facebook And LinkedIn by SteveKimLaw
Volcano Still Has Plenty To Prove by Stephen Simpson
Men's Wearhouse: How Good Does An LBO Look? by Jane Edmondson
Korean Partner Positions Pluristem To Be Cell Therapy Leader by Sharon di Stefano
Gold Speculators Should Consider Pretium Resources by Ben Kramer-Miller
Coles Presses Home Onyx's Advantage by EP Vantage
Sentiment On Greece Reverses: NBG Shares Plunge 86% In 6 Weeks by Stephen Percoco
Onyx Could Be Worth Substantially More by Harlan Kessler
Onyx Pharmaceuticals Rejected Amgen's $120 Per Share Acquiring Offer - Part 1 by Bio Vantage
Is It Time To Double Down On BlackBerry? by Chris Lau
Is The TJX Company Taking Over For J.C. Penney? by Thinking Big
Goldman Sachs Is An Outstanding Investment by Andrew Brady
Philip Morris - Why I'm Worried by Ry The Kid
7 Reasons To Buy Domtar Corporation by Derek Chipman
Online Poker- Why Facebook Will Be The Big Winner by Capital Recharge
Kinder Morgan Energy Partners Is An Attractive Long-Term Investment by Core Equity Research
Time To Consider HollyFrontier? by Richard Evans
Endeavour Silver: Is This Silver Miner Toast Or Will It Survive? by The Investment Doctor
Bristol-Myers Squibb: Valuation Dependent On Pipeline by Tom Armistead
Verizon: Attractive Valuation With Promising Future by investec
Improper Analysis Of Belviq's IMS Prescription Data Causes A 9% Sell-Off Of Arena On Good News by Reasonable Risk
Heins' Mobile End Computing Vision Comes To An End; So Must He by Michael Collins
What Management Thinks About BP's True Value by Alexander Valtsev
The Risk And Reward Of Uni-Pixel, Inc. - Tread Lightly by Market Exclusive
Intel's Skylake Is A Monster by Ashraf Eassa
Can Joe's Jeans Double? by Jacob Steinberg
Panera Bread: Excellent Management by Nikhil Raheja
Is Nokia Still A Buy? by Shareholders Unite
CH Robinson: The Supply-Shock Catalyst by Myles McCabe
Arena's Second Week Sales - Not Bad, But Not Good Either by Spencer Osborne
Is The Sell-Off Over For Walter Energy? by Kevin Quon
So Much For BlackBerry Killing Nokia by Jacob Steinberg
Medidata Solutions: Positioned To Ultimately, Indirectly, Positively Impact Mankind by Rochelle Jenks
Keep First American On Your Radar by Morningstar
Finish Line Teams Up With Macy's by Aaron Murdock
Teradata: Heavy Hitter In A 9 Month Slump by Ted Stamas
Nokia Mugs Siemens by Redrut
Will Big Changes At Apricus Biosciences Make It A Winning Stock? by C.R. Jackson
Cowen Group Is Positioned To Double Or Triple Within 18 Months by Regarded Solutions
BlackBerry: Why We Are Not Selling Our Shares by Tufenk
KBR To Benefit From LNG Projects Surge by Stone Fox Capital
Short Ideas
Polar Bared: Once Again, Stay Away From Polar Petroleum by Christopher Drose
Suntech - For How Long Will It Kick The Can? by Sneha Shah
Why I Won't Be Buying Netflix Anytime Soon by Regarded Solutions
Coca-Cola: Short The Market's Oversight by QuandaryFX
Pure Arbitrage In Brown-Forman's Class Structure by Marc Gilbert
Quick Picks & Lists
How To Find Value And Income In This Market: A Look At The Beverage Aristocrats by Richard Berger
These 5 Low P/E Stocks Could Pop If They Beat Earnings Again by Insider Monkey
Solid Risk/Reward Found Among Israeli Small Cap Stocks by William Garrison
Bull Of The Day: Smith & Wesson by Zacks Investment Research
Bear Of The Day: Actuant by Zacks Investment Research
5 Natural Gas Transportation Stocks For 2013: June Update by Michael Fitzsimmons
5 High-Flying Stocks Short Sellers Are Targeting by Insider Monkey
Two Stocks With Takeover Written All Over Them by Mark Krieger
10 Clean Energy Stocks For 2013: First Half Review by Tom Konrad
Where 5 Giants Battle, Only 2 Can Win... by Dhierin Bechai
Should You Add These Energy Firms To Your Portfolio? by Sarfaraz A. Khan
Improving Consumer Expectations Bode Well For Briggs & Stratton by Robert Loftus
Are Any Big Oil Stocks A Buy Right Now? by Richard Evans
IP Investment Share Structure by IP Hawk
Cramer's Picks
Cramer's Lightning Round - Vale Is A House Of Pain (7/1/13) by SA Editor Miriam Metzinger
Cramer's Mad Money - Noodles & Company Is The Son Of Chipotle (7/1/13) by SA Editor Miriam Metzinger
Fund Holdings
Individual Investor Portfolio Update: Transportation-Related Stocks Are Beating Market Indices by James Sands
Insider Ownership
2 Biotechs With Recent Intensive Insider Selling by Markus Aarnio
2 Industrial Goods Mid Caps With Recent Intensive Insider Selling by Markus Aarnio
IPO Analysis
Portola Pharmaceuticals: Developing The Novel Therapies In Blood Clot Formation Disorders by Vivek Gupta
Is Noodles The New Chipotle? by John Gordon
Why are you receiving this? You subscribed to Investing Ideas at Seeking Alpha.
Unsubscribe from this email or manage all your Seeking Alpha email choices here.
To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders.
Sent by Seeking Alpha, 345 7th Ave. Suite 1400 New York, NY 10001
No hay comentarios:
Publicar un comentario